TCC1727
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 21, 2025
A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: Beijing Tide Pharmaceutical Co., Ltd | N=40 ➔ 56 | Trial completion date: Sep 2025 ➔ Dec 2025 | Trial primary completion date: Mar 2025 ➔ Jul 2025
Enrollment change • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
December 21, 2023
A Phase I/II Clinical Study in Patients With Advanced Solid Tumor.
(clinicaltrials.gov)
- P1/2 | N=40 | Recruiting | Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
August 01, 2023
A Phase I/II Clinical Study in Patients With Advanced Solid Tumor.
(clinicaltrials.gov)
- P1/2 | N=40 | Not yet recruiting | Sponsor: Beijing Tide Pharmaceutical Co., Ltd
Metastases • New P1/2 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1